Brandes Investment Partners 13F: Adds $92M to UNH Stake

Brandes Investment Partners Grows UnitedHealth Group Holding

Brandes Investment Partners increased its investment in UnitedHealth Group Incorporated (NYSE: UNH) during the period ended May 15, 2026, according to a Form 13F filing with the Securities and Exchange Commission. The value-driven investment firm added 221,821 shares to its portfolio, marking a 55.4% increase from the prior quarter. That expansion brought the firm's total ownership to 621,884 shares, with an estimated value of $258.4 million at the reporting date.

UnitedHealth Group Stock Trades Near Recent Levels

Shares of UnitedHealth Group changed hands around $415.63 on Saturday. The healthcare provider trades well inside its 52-week boundaries of $255.97 and $461.62. The company carries a forward P/E ratio of 17.55 based on upcoming earnings estimates, alongside a trailing P/E ratio of 26.15.

Dividend and Yield Details

UnitedHealth Group supports its shareholders with an annual dividend that yields 2.28%. The payout ratio stands at 57.56%, leaving room for the company to return capital while reinvesting in its core healthcare operations.

Insider Buying and Selling at UnitedHealth Group Incorporated

Company insiders were active in June 2026. On June 23, 2026, Dennis Stankiewicz, Chief Accounting Officer, acquired 51 shares. Patrick Hugh Conway, Chief Executive Officer of Optum, picked up 83 shares on the same day. Additional purchases included 8 shares by Kristen Gil, 3 shares by Scott Gottlieb, 41 shares by John Noseworthy, and 76 shares by Timothy John Noel, Chief Executive Officer of UHC. These routine transactions occurred across leadership ranks.

Analysts Set New Price Targets

Wall Street firms updated their views on UnitedHealth Group through October 2026. On October 16, 2026, Bernstein maintained an outperform rating with a $500.00 price target, down from $512.00. On the same day, JP Morgan kept an overweight rating while lifting its target to $524.00 from $516.00. TD Cowen maintained a hold rating with a $402.00 target on October 15, 2026, and Piper Sandler kept an overweight rating with a $504.00 target on October 14, 2026. Barclays maintained an overweight rating with a $440.00 target on October 14, 2026, and Baird kept a neutral rating with a $427.00 target on the same day. Overall, the stock holds a consensus buy rating with a mean price target of $477.04 across 25 analyst opinions.

Inside UnitedHealth Group

UnitedHealth Group Incorporated operates healthcare networks and benefit plans across the United States and internationally. It delivers services through segments focused on patient care, health information technology, pharmacy care, and insurance coverage. The company employs roughly 390,000 people and maintains its headquarters in Eden Prairie, Minnesota.

What to Watch at UnitedHealth Group Incorporated

Because 13F filings look backward, these figures reflect holdings as of May 15, 2026, and might not show the fund's current position. Investors will watch for subsequent disclosures to see if Brandes continues adding to its stake, alongside the company's next earnings report scheduled for January 26, 2027.